| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EJCTS/EZW313 |
| 10.1093/EUROPACE/EUW295 | ||
| P698 | PubMed publication ID | 27567465 |
| 27663299 |
| P50 | author | Piotr Ponikowski | Q22114836 |
| Hans-Christoph Diener | Q25935337 | ||
| Raphael Rosenhek | Q114244154 | ||
| Stefano Benussi | Q114403186 | ||
| Panagiotis E Vardas | Q114413205 | ||
| Stefan Agewall | Q114420238 | ||
| Bogdan Alexandru Popescu | Q114429132 | ||
| Spiridon Deftereos | Q114429133 | ||
| Maxine Guenoun | Q114429134 | ||
| Athanasios Manolis | Q114429135 | ||
| Paulus Kirchhof | Q38326091 | ||
| Jeroen Hendriks | Q38545855 | ||
| Antonis S. Manolis | Q39188670 | ||
| Scipione Carerj | Q41774960 | ||
| José M. Ferro | Q41776108 | ||
| Dipak Kotecha | Q47805074 | ||
| John McMurray | Q56633150 | ||
| Donna Fitzsimons | Q57052635 | ||
| Philippe Kolh | Q59004337 | ||
| Anders Ahlsson | Q59173372 | ||
| Gregory Lip | Q60393087 | ||
| Juan Luis Tamargo Menéndez | Q61936103 | ||
| Gerasimos Filippatos | Q63107352 | ||
| Frank Ruschitzka | Q63107473 | ||
| Stephan Windecker | Q63256285 | ||
| Werner Budts | Q63256605 | ||
| Gonzalo Barón-Esquivias | Q64213535 | ||
| Dan Atar | Q65660970 | ||
| Gerhard Hindricks | Q67189332 | ||
| Ulrich Schotten | Q74771070 | ||
| Katja Zeppenfeld | Q76741481 | ||
| Piotr Suwalski | Q85551345 | ||
| Raffaele De Caterina | Q87797284 | ||
| Hein Heidbuchel | Q90710858 | ||
| Adriaan A Voors | Q91537232 | ||
| Bulent Gorenek | Q91904948 | ||
| Filip Casselman | Q95331073 | ||
| Isabelle C Van Gelder | Q95921326 | ||
| Manuel Castellà | Q101125473 | ||
| Irina Savelieva | Q102066745 | ||
| Jonas Oldgren | Q106086753 | ||
| Dobromir Dobrev | Q110902296 | ||
| Stefan H Hohnloser | Q110902934 | ||
| José Luis Zamorano | Q114244147 | ||
| P2093 | author name string | Barbara Casadei | |
| Sanjay Sharma | |||
| Antonio Coca | |||
| John Camm | |||
| Bart Van Putte | |||
| Clare J. Taylor | |||
| P2860 | cites work | Preoperative statin therapy for patients undergoing cardiac surgery | Q24200475 |
| Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients: Results From the Randomized OASIS Trial. | Q46132348 | ||
| P2507 | corrigendum / erratum | Corrigendum to: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS | Q87731581 |
| P433 | issue | 11 | |
| 5 | |||
| P921 | main subject | Atrial Fibrillation | Q815819 |
| collaboration | Q1145523 | ||
| P304 | page(s) | 1609-1678 | |
| e1-e88 | |||
| P577 | publication date | 2016-08-27 | |
| 2016-09-23 | |||
| P1433 | published in | European Journal of Cardio-Thoracic Surgery | Q2178577 |
| EP Europace | Q2596718 | ||
| P1476 | title | 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS | |
| P478 | volume | 50 | |
| 18 |
| Q64282962 | "AF HeartTeam" Guided Indication for Stand-alone Thoracoscopic Left Atrial Ablation and Left Atrial Appendage Closure |
| Q64102626 | "Pill-in-the-Pocket" Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism |
| Q39150201 | 'It's like a frog leaping about in your chest': Illness and treatment perceptions in persistent atrial fibrillation |
| Q55263071 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q50065204 | 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery |
| Q50089557 | 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. |
| Q45059153 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q46658026 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q42172443 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. |
| Q42373398 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary |
| Q38647787 | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| Q45069696 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary |
| Q64080237 | 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension |
| Q92113333 | 2019 EACTS Expert Consensus on long-term mechanical circulatory support |
| Q47779977 | A COMPASS to REACH the right patients with thrombocardiology: benefits, risks, and future of the new concept. |
| Q40071567 | A Method Sustaining the Bioelectric, Biophysical, and Bioenergetic Function of Cultured Rabbit Atrial Cells |
| Q59792032 | A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation |
| Q91709347 | A Very Late and Persistent Thrombosis after Left Atrial Appendage Occlusion |
| Q91601311 | A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin |
| Q64816432 | A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. |
| Q90188925 | A minimally invasive all-in-one approach for patients with left anterior descending artery disease and atrial fibrillation |
| Q58616341 | A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants |
| Q89023353 | A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation |
| Q48506800 | A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study |
| Q38650658 | ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives. |
| Q38650580 | Ablative Radiotherapy as a Noninvasive Alternative to Catheter Ablation for Cardiac Arrhythmias |
| Q52343211 | Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation. |
| Q90395849 | Adenosine plasma level in patients with paroxysmal or persistent atrial fibrillation and normal heart during ablation procedure and/or cardioversion |
| Q39159567 | Adjunctive ablation strategies improve the efficacy of pulmonary vein isolation in non-paroxysmal atrial fibrillation: a systematic review and meta-analysis |
| Q49671028 | Advances in cardiac cellular electrophysiology - Relevance for clinical translation |
| Q51758666 | Aerobic Interval Training Prevents Age-Dependent Vulnerability to Atrial Fibrillation in Rodents. |
| Q90476456 | An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial |
| Q90224869 | An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter |
| Q47691480 | An illness-specific version of the Revised Illness Perception Questionnaire in patients with atrial fibrillation (AF IPQ-R): Unpacking beliefs about treatment control, personal control and symptom triggers. |
| Q55026390 | Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation. |
| Q58743469 | Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging |
| Q90055787 | Anticoagulant and antiplatelet combined therapy in patients 75 years and over with atrial fibrillation: a prospective observational study assessing adherence to clinical guidelines |
| Q55047549 | Anticoagulation Resumption After Intracerebral Hemorrhage. |
| Q89674776 | Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study |
| Q93086115 | Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study |
| Q47984703 | Anticoagulation after coronary stenting: a systemic review |
| Q90533023 | Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada |
| Q64063501 | Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low-Dose Non-Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin? |
| Q90733611 | Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry |
| Q89220120 | Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose |
| Q59795416 | Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis |
| Q58751103 | Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities |
| Q92425851 | Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease |
| Q52804575 | Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? |
| Q46249138 | Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis |
| Q57418595 | Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: a cross-sectional analysis of The Rotterdam Study |
| Q52585961 | Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial. |
| Q52631077 | Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. |
| Q38605644 | Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon |
| Q92359328 | Applying sinus node function testing to evaluate perioperative management for patients suffering from tachycardia-bradycardia syndrome before atrial fibrillation ablation |
| Q95938187 | Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score |
| Q88955166 | Are we doing enough to detect paroxysmal atrial fibrillation after an acute ischaemic stroke? Survey of cardiac monitoring methods among stroke physicians |
| Q61800610 | Are we there yet with patent foramen ovale closure for secondary prevention in cryptogenic stroke? A systematic review and meta-analysis of randomized trials |
| Q92513067 | Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension |
| Q88190239 | Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater |
| Q64094029 | Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan |
| Q99714489 | Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease |
| Q54949321 | Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. |
| Q64091941 | Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study |
| Q92129583 | Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy |
| Q47221597 | Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery. |
| Q64250567 | Association of Autoantibodies against M2-Muscarinic Acetylcholine Receptor with Atrial Fibrosis in Atrial Fibrillation Patients |
| Q96029587 | Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage |
| Q89900042 | Association of Obesity Measures with Atrial Fibrillation Recurrence After Cryoablation in Patients with Paroxysmal Atrial Fibrillation |
| Q92438188 | Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis |
| Q64901370 | Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. |
| Q38739817 | Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population. |
| Q50077941 | Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. |
| Q58130007 | Atrial Fibrillation Detection Using a Novel Cardiac Ambulatory Monitor Based on Photo-Plethysmography at the Wrist |
| Q47833921 | Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke. |
| Q42158658 | Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients? |
| Q58127466 | Atrial Fibrillation and Risk of Cancer: A Danish Population-Based Cohort Study |
| Q90229012 | Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants |
| Q92802219 | Atrial Fibrillation in Older People: Concepts and Controversies |
| Q90152328 | Atrial Fibrillation in Patients with Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis |
| Q57114130 | Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation |
| Q96647286 | Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation |
| Q92389876 | Atrial fibrillation ablation in practice: assessing CABANA generalizability |
| Q90283807 | Atrial fibrillation and frailty |
| Q41378902 | Atrial fibrillation and psychological factors: a systematic review. |
| Q38810934 | Atrial fibrillation as a risk factor for cognitive decline and dementia. |
| Q57164291 | Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants? |
| Q47139884 | Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study |
| Q48025982 | Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion |
| Q89795739 | Atrial fibrillation surgery and mitral repair |
| Q45325925 | Atrial function is altered in lone paroxysmal atrial fibrillation in male endurance veteran athletes |
| Q92390281 | Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence |
| Q99578707 | Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making |
| Q49024258 | A clinical approach to arrhythmias revisited in 2018 : From ECG over noninvasive and invasive electrophysiology to advanced imaging |
| Q33601396 | Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation). |
| Q47776586 | Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials |
| Q96304359 | Beyond CHA2DS2-VASc in atrial fibrillation: the atrium and the risk of stroke |
| Q97525518 | Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation |
| Q47114683 | Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study. |
| Q38600440 | Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data |
| Q47803747 | Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients |
| Q90397068 | Body Composition in Patients with Atrial Fibrillation |
| Q91813013 | Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study |
| Q50138834 | Burden of atrial high-rate episodes and risk of stroke: a systematic review. |
| Q64948010 | CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry. |
| Q99240645 | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| Q90248065 | Calcium Handling Defects and Cardiac Arrhythmia Syndromes |
| Q39128014 | Calcium-mediated cellular triggered activity in atrial fibrillation |
| Q47104310 | Can we spice up our Christmas dinner? : Busting the myth of the 'Chinese restaurant syndrome'. |
| Q89564207 | Cardiac Arrhythmias and Pregnancy |
| Q89843705 | Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience |
| Q58751785 | Cardiac magnetic resonance using late gadolinium enhancement and atrial T1 mapping predicts poor outcome in patients with atrial fibrillation after catheter ablation therapy |
| Q38636762 | Cardiac mapping and pulmonary vein isolation using a novel ablation catheter with tip mini electrodes |
| Q61454621 | Cardiovascular imaging in cardio-oncology |
| Q48739342 | Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin |
| Q38653456 | Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians |
| Q98578056 | Catheter Ablation vs. Medical Treatment in Patients With Atrial Fibrillation |
| Q53276291 | Catheter ablation as first-line in atrial fibrillation: is rhythm control finally better than rate control? |
| Q100533956 | Catheter ablation for atrial fibrillation: current indications and evolving technologies |
| Q53542653 | Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society. |
| Q64228072 | Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis |
| Q48252521 | Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications? |
| Q52651128 | Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials. |
| Q64054095 | Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device |
| Q91877103 | Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation |
| Q96958962 | Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF |
| Q90675622 | Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis |
| Q39223539 | Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes |
| Q50951062 | Characteristics of the new AtriCure cryoFORM® cryoablation probe for the surgical treatment of cardiac arrhythmias. |
| Q50907596 | Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge. |
| Q51760732 | Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study. |
| Q60047008 | Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins |
| Q57750151 | Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference |
| Q60049202 | Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade |
| Q92661558 | Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation |
| Q91120837 | Clinical analysis of antithrombotic treatment and occurrence of stroke in elderly patients with nonvalvular persistent atrial fibrillation |
| Q38716313 | Clinical background including anticoagulant therapy in patients with atrial fibrillation in a community-based survey: the Saitama AF Registry |
| Q91653401 | Clinical characteristics and antithrombotic prescription in elderly hospitalized atrial fibrillation patients: A cross-sectional analysis of a Swedish single-center clinical cohort |
| Q64984733 | Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study. |
| Q61804173 | Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program |
| Q39339719 | Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review |
| Q90712949 | Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation |
| Q47099909 | Clinical significance of atrial high-rate episodes for thromboembolic events in Japanese population |
| Q97570312 | Combined Therapy of Catheter Ablation and Left Atrial Appendage Closure for Patients with Atrial Fibrillation: A Case-Control Study |
| Q47378111 | Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up |
| Q52777555 | Commentary: PLAAF score as a novel predictor of long-term outcome after second-generation cryoballoon pulmonary vein isolation. |
| Q49907136 | Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis |
| Q58800204 | Comparison of Radiofrequency Ablation and Cryoablation for the Recovery of Atrial Contractility and Survival |
| Q47427421 | Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants |
| Q47121090 | Comparison of the Efficancy and Complication Rates of the Hybrid Maze, Complete Cox-Maze and Catheter Ablation in the Treatment of Atrial Fibrillation |
| Q48312982 | Comparison of the three conventional methods for the postoperative atrial fibrillation prediction. |
| Q50297967 | Complications of Atrial Fibrillation Cryoablation. |
| Q47614939 | Complications of pulmonary vein isolation in atrial fibrillation: predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry |
| Q89754967 | Concomitant procedures using minimally access |
| Q52603884 | Contact-Free Screening of Atrial Fibrillation by a Smartphone Using Facial Pulsatile Photoplethysmographic Signals. |
| Q92976934 | Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry |
| Q48354706 | Coronary sinus signal amplitude predicts left atrial scarring |
| Q38976981 | Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey. |
| Q50085936 | Current indications for left atrial appendage occlusion |
| Q42363653 | Current practice of Dutch cardiologists in detecting and diagnosing atrial fibrillation: results of an online case vignette study |
| Q60309571 | DC cardioversion of atrial fibrillation and atrial flutter in the emergency department: improving specialist protocols for the generalist |
| Q61455768 | Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report |
| Q64118635 | Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial |
| Q38821650 | Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients. |
| Q50659562 | Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures. |
| Q63389316 | Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation |
| Q62489866 | Deep learning for cardiovascular medicine: a practical primer |
| Q38878668 | Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis |
| Q57399031 | Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO) |
| Q47615006 | Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score. |
| Q93029665 | Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group |
| Q92783316 | Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion |
| Q99239098 | Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations |
| Q40112799 | Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study |
| Q93022817 | Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction |
| Q37739398 | Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis |
| Q61807914 | Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation |
| Q48101005 | Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis |
| Q50123510 | Direct oral anticoagulant reversal: how, when and issues faced |
| Q90264380 | Directed Networks as a Novel Way to Describe and Analyze Cardiac Excitation: Directed Graph Mapping |
| Q47737710 | Discovery methods of coagulation-inhibiting drugs. |
| Q64889811 | Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. |
| Q58728367 | Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia |
| Q50089744 | Does CHA2DS2-VASc score predict ischaemic stroke in chronic obstructive pulmonary disease? |
| Q52597322 | Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study. |
| Q55041184 | Dynamic stroke risk scores of atrial fibrillation. |
| Q50119076 | Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Tria |
| Q64234327 | Early experience of thoracoscopic vs. catheter ablation for atrial fibrillation |
| Q64900754 | Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke. |
| Q56516532 | Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design |
| Q89280404 | Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study |
| Q55662488 | Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines. |
| Q54965103 | Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation. |
| Q64994114 | Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation. |
| Q57288537 | Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure |
| Q47134346 | Effectiveness of catheter ablation of atrial fibrillation: are we at the dawn of a new era? |
| Q58130065 | Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study |
| Q90199710 | Efficacy and safety of catheter ablation for atrial fibrillation in congenital heart disease - A systematic review and meta-analysis |
| Q54267504 | Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation. |
| Q64950848 | Electrocardiographic RR Interval Dynamic Analysis to Identify Acute Stroke Patients at High Risk for Atrial Fibrillation Episodes During Stroke Unit Admission. |
| Q89964392 | Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis |
| Q90374027 | Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014 |
| Q57103400 | Emergency Surgery in a Critically Ill Patient with Major Drug-Induced Bleeding and Severe Ischaemic Heart Failure |
| Q47291765 | Empowerment of athletes with cardiac disorders: a new paradigm |
| Q42696103 | Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery. |
| Q60302713 | Epidemiological Characteristics of Atrial Fibrillation in Southern China: Results from the Guangzhou Heart Study |
| Q88684953 | Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry - The TAC 2 Study |
| Q55208569 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? |
| Q57071918 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? |
| Q48529316 | European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers |
| Q99570589 | Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation |
| Q42129335 | Evaluating the morphology of the left atrial appendage by a transesophageal echocardiographic 3-dimensional printed model |
| Q99406812 | Evaluation of Mortality in Atrial Fibrillation: Clinical Outcomes in Digital Electrocardiography (CODE) Study |
| Q90392227 | Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol |
| Q34550885 | Exercise-based cardiac rehabilitation for adults with atrial fibrillation. |
| Q52804026 | Expert opinion paper on atrial fibrillation detection after ischemic stroke. |
| Q94263931 | External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta‐analysis |
| Q90054035 | Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter? |
| Q55101913 | Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study. |
| Q89876583 | Feasibility, safety, and acute efficacy of the fourth-generation cryoballoon for ablation of atrial fibrillation: Another step forward? |
| Q58123839 | Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study |
| Q48171488 | First description of a double-wall balloon breach during cryoballoon ablation for atrial fibrillation. |
| Q55363484 | Force Trends and Pulsatility for Catheter Contact Identification in Intracardiac Electrograms during Arrhythmia Ablation. |
| Q50080851 | Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey |
| Q61814407 | Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry |
| Q94467157 | Gender-specific association between body mass index and all-cause mortality in patients with atrial fibrillation |
| Q57283285 | German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management |
| Q90656095 | Heart Failure and Stroke |
| Q58559241 | Hemoptysis as a side effect of cryoballoon pulmonary vein isolation in atrial fibrillation: a retrospective case-control study |
| Q93081311 | Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study |
| Q92105584 | Heterogeneous Effects of Fibroblast-Myocyte Coupling in Different Regions of the Human Atria Under Conditions of Atrial Fibrillation |
| Q55251879 | High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation. |
| Q92509480 | High prevalence of hyperlipidaemia in patients with AV re-entry tachycardia and AV nodal re-entry tachycardia |
| Q42330286 | High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. |
| Q90041303 | High-Normal Thyroid-Stimulating Hormone Shows a Potential Causal Association With Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation |
| Q64074196 | High-resolution Mapping in Patients with Persistent AF |
| Q64238446 | High-sensitivity cardiac troponin T as an independent predictor of stroke in patients admitted to an emergency department with atrial fibrillation |
| Q92481798 | Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban |
| Q62667746 | How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure |
| Q52663517 | How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients. |
| Q48231790 | How to perform posterior wall isolation in catheter ablation for atrial fibrillation. |
| Q64231245 | Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation |
| Q64973652 | Hybrid thoracoscopic surgical and transvenous catheter ablation versus transvenous catheter ablation in persistent and longstanding persistent atrial fibrillation (HARTCAP-AF): study protocol for a randomized trial. |
| Q40275970 | Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes |
| Q38677229 | Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring |
| Q64261109 | Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis |
| Q39448172 | Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. |
| Q56957067 | Identification of active atrial fibrillation sources and their discrimination from passive rotors using electrographical flow mapping |
| Q42353591 | Identifying the predictors of hematoma after device implantation: Closing in on the suspects with an aim to prevent the menace? |
| Q92888502 | Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study |
| Q92011613 | Imbalance of ER and Mitochondria Interactions: Prelude to Cardiac Ageing and Disease? |
| Q90462924 | Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study |
| Q89807080 | Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban |
| Q90102718 | Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation |
| Q88427478 | Impact of an additional right pulmonary vein on second-generation cryoballoon ablation for atrial fibrillation: a propensity matched score study |
| Q89986663 | Impact of re-definition of paroxysmal and persistent atrial fibrillation in the 2012 and 2016 European Society of Cardiology atrial fibrillation guidelines on outcomes after pulmonary vein isolation |
| Q49034449 | Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the 'CLOSE'-protocol |
| Q91771781 | In Reply to Keskin and Orhan |
| Q90529172 | In-Hospital Postoperative Atrial Fibrillation Indicates a Poorer Clinical Outcome after Myectomy for Obstructive Hypertrophic Cardiomyopathy |
| Q90569322 | Incidence and Predictors of Atrial Fibrillation Progression |
| Q38371641 | Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study |
| Q47604909 | Incidence of postoperative atrial fibrillation recurrence in patients discharged in sinus rhythm after cardiac surgery: a systematic review and meta-analysis. |
| Q47291952 | Incidence of thromboembolic and bleeding events in patients with newly diagnosed nonvalvular atrial fibrillation: An Asian multicenter retrospective cohort study in Singapore |
| Q99406821 | Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality |
| Q39449914 | Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics |
| Q92318136 | Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis |
| Q92968033 | Individualised Approaches for Catheter Ablation of AF: Patient Selection and Procedural Endpoints |
| Q47133610 | Influence of Severe Carotid Stenosis on Cognition, Depressive Symptoms and Quality of Life |
| Q92172294 | Influence of heart rate control on exercise capacity and quality of life in patients with permanent atrial fibrillation |
| Q47883450 | Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference |
| Q92515835 | Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population |
| Q55021386 | Intraoperative Inducibility of Atrial Fibrillation Does Not Predict Early Postoperative Atrial Fibrillation. |
| Q49963925 | Intraoperative epicardial focal pulmonary venous electrocardiography in patients with atrial fibrillation |
| Q90679647 | Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation |
| Q91526530 | Inverse Correlation Between Left Atrial Appendage Function and CHA2DS2-VASc Score in Patients with Atrial Flutter |
| Q38848144 | Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review. |
| Q48627362 | Is it reasonable to use a lower DOAC dose in some patients with VTE? NO. |
| Q88961925 | Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stro |
| Q64106253 | Is the presence of left atrial diverticulum associated with recurrence in patients undergoing catheter ablation for atrial fibrillation? |
| Q60305883 | Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation? |
| Q55174495 | Landiolol for managing atrial fibrillation in intensive care. |
| Q55025863 | Landiolol for managing atrial fibrillation in post-cardiac surgery. |
| Q55246945 | Landiolol for managing post-operative atrial fibrillation. |
| Q55312031 | Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction. |
| Q92312176 | Left Atrial Appendage Transcatheter Occlusion with AMPLATZER™ Amulet™ Device: Real Life Data with Mid-Term Follow-Up Results |
| Q57173028 | Left Atrial Appendages Occlusion: Current Status and Prospective |
| Q92675026 | Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation |
| Q64063876 | Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry |
| Q47583659 | Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey |
| Q52572061 | Left atrial deformation as a potent predictor for paroxysmal atrial fibrillation in patients with end-stage renal disease. |
| Q47112205 | Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device. |
| Q58606791 | Left atrial epicardial adipose tissue radiodensity is associated with electrophysiological properties of atrial myocardium in patients with atrial fibrillation |
| Q93031914 | Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation |
| Q48335705 | Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation |
| Q44176871 | Left ventricular ejection fraction and left atrium diameter related to new-onset atrial fibrillation following acute myocardial infarction: a systematic review and meta-analysis. |
| Q89622283 | Left ventricular fibrosis by extracellular volume fraction and the risk of atrial fibrillation recurrence after catheter ablation |
| Q90264357 | Lesion index: a novel guide in the path of successful pulmonary vein isolation |
| Q92072502 | Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation |
| Q55054515 | Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation. |
| Q51244493 | Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China. |
| Q98290037 | Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation |
| Q41627539 | Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores |
| Q52625526 | Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation. |
| Q90608098 | Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Left-Sided Heart Valve Surgery |
| Q38955911 | Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs |
| Q49488588 | Management of Arrhythmias in Athletes: Atrial Fibrillation, Premature Ventricular Contractions, and Ventricular Tachycardia |
| Q99560183 | Management of catheter ablation in arrhythmia patients during the coronavirus disease 2019 epidemic |
| Q57183611 | Management of patients with stroke treated with direct oral anticoagulants |
| Q95641902 | Management of the COPD Patient with Comorbidities: An Experts Recommendation Document |
| Q64993615 | Massive air embolism caused by an atrioesophageal fistula following isolation of the pulmonary veins for atrial fibrillation. |
| Q50037716 | Mechanical discordance between left atrium and left atrial appendage |
| Q61800302 | Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation |
| Q88769562 | Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation |
| Q98174681 | Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients |
| Q89052554 | Methodologic Differences Across Studies of Patients With Atrial Fibrillation Lead to Varying Estimates of Stroke Risk |
| Q38886518 | Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†. |
| Q64946884 | Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation. |
| Q49716500 | Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts |
| Q64113554 | Mobile Phone-Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care: Diagnostic Accuracy Study of the FibriCheck App |
| Q47616826 | Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. |
| Q90571471 | Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project |
| Q58694840 | Muscle Thickness and Curvature Influence Atrial Conduction Velocities |
| Q47135358 | Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era. |
| Q37617079 | Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care. |
| Q64058352 | New onset of chest pain: the importance of remote monitoring |
| Q99616239 | New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke |
| Q91923022 | Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis |
| Q39452481 | Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal. |
| Q64965003 | Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke. |
| Q53281556 | Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Q47827695 | Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion. |
| Q38810994 | Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation. |
| Q64961894 | Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome. |
| Q89768426 | Noninvasive stereotactic radioablation for the treatment of atrial fibrillation: First-in-man experience |
| Q94230261 | Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis |
| Q90171191 | Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients with Chronic Nonvalvular Atrial Fibrillation |
| Q99581966 | Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review |
| Q100495735 | On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation |
| Q47658811 | One-stage Approach for Hybrid Atrial Fibrillation Treatment |
| Q91840732 | Opportunistic screening for atrial fibrillation with a single lead device in geriatric patients |
| Q58732255 | Opposite relations of epicardial adipose tissue to left atrial size in paroxysmal and permanent atrial fibrillation |
| Q92741601 | Optimal Choice of Pharmacological Therapy - Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation |
| Q50003159 | Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation |
| Q88543066 | Optimal nonvitamin K antagonist oral anticoagulant therapy in a warfarin-sensitive patient after left atrial appendage closure: A case report |
| Q48273854 | Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice. |
| Q49349357 | Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy? |
| Q64928773 | Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study. |
| Q57797958 | Ortner's syndrome after cryoballoon ablation |
| Q56355648 | Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States |
| Q47827722 | Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study. |
| Q95729004 | Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation |
| Q33800597 | PITX2-dependent gene regulation in atrial fibrillation and rhythm control |
| Q89868217 | Paroxysmal Atrial Fibrillation: Insight Into the Intimate Mechanisms of Coagulation |
| Q90701887 | Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Regis |
| Q97538196 | Path to precision: prevention of post-operative atrial fibrillation |
| Q50077869 | Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure |
| Q92592575 | Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment |
| Q91643495 | Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study) |
| Q50868122 | Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument. |
| Q88288804 | Patient-specific catheter shaping for the minimally invasive closure of the left atrial appendage |
| Q41490689 | Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP |
| Q52590971 | Percutaneous Closure of Left Atrial Appendage significantly affects Lipidome Metabolism. |
| Q93186565 | Percutaneous left atrial appendage closure using the LAmbre device. First clinical results in Poland |
| Q47330371 | Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review |
| Q49908617 | Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review |
| Q57037668 | Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study |
| Q58615304 | Performance of an atrial fibrillation detection algorithm using continuous pulse wave monitoring |
| Q90289499 | Peri-interventional embolization of left atrial appendage occlusion devices: two manoeuvers of successful retrieval |
| Q47713122 | Periprocedural Anticoagulation Management for Atrial Fibrillation Ablation: Current Knowledge and Future Directions |
| Q55111370 | Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants. |
| Q47355542 | Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). |
| Q64292351 | Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization |
| Q90319412 | Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients |
| Q91585084 | Practical guide to choosing dabigatran 150 mg twice daily or apixaban 5 mg twice daily for patients with atrial fibrillation |
| Q58127103 | Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores |
| Q90027114 | Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores |
| Q90751047 | Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models |
| Q89502925 | Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis |
| Q58714671 | Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation |
| Q92367643 | Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant) |
| Q104751415 | Predictive value of H2 FPEF score in patients with heart failure with preserved ejection fraction |
| Q89278320 | Predictive value of unshielded magnetocardiographic mapping to differentiate atrial fibrillation patients from healthy subjects |
| Q92616761 | Predictors of Recurrence of AF in Patients After Radiofrequency Ablation |
| Q49813399 | Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation |
| Q33766891 | Predisposing factors for atrial fibrillation in the elderly |
| Q90675790 | Prevalence and Characteristics of Subclinical Atrial Fibrillation in a Community-Dwelling Elderly Population: The ARIC Study |
| Q91645788 | Prevalence and Incidence of Atrial Fibrillation and Other Arrhythmias in the General Older Population: Findings From the Swedish National Study on Aging and Care |
| Q48199534 | Prevalence and predictive factors of left atrial tachycardia occurring after second-generation cryoballoon ablation of atrial fibrillation |
| Q47733658 | Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation |
| Q90095018 | Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation |
| Q88011603 | Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study |
| Q94525559 | Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure |
| Q89483513 | Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction |
| Q38377313 | Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation |
| Q90102790 | Programming Pacemakers to Reduce and Terminate Atrial Fibrillation |
| Q48059181 | Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation. |
| Q99578855 | Pulmonary vein isolation implemented by second-generation cryoballoon for treating hypertrophic cardiomyopathy patients with symptomatic atrial fibrillation: a case-control study |
| Q90121890 | Pulmonary vein isolation treats symptomatic AF in a patient with Lamin A/C mutation: case report and review of the literature |
| Q31149219 | Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data |
| Q48563042 | Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. |
| Q94503728 | Quantitative and Qualitative Analysis on Sex and Gender in Preparatory Material for National Medical Examination in Germany and the United States |
| Q90447225 | RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study |
| Q52594805 | Rabbit model to simulate the residual conduction gaps after radiofrequency ablation on the anterior wall of left atrial appendage. |
| Q61808973 | Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis |
| Q52624637 | Real-Time Rotational Activity Detection in Atrial Fibrillation. |
| Q98771556 | Real-Time Ventricular Cancellation in Unipolar Atrial Fibrillation Electrograms |
| Q101045322 | Real-World Comparative Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants versus Warfarin in a Developing Country |
| Q92222392 | Real-time photoacoustic assessment of radiofrequency ablation lesion formation in the left atrium |
| Q88085870 | Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study |
| Q48362648 | Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies. |
| Q99565674 | Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK |
| Q92914386 | Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France |
| Q38665579 | Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease |
| Q42370098 | Recent advances in rhythm control for atrial fibrillation |
| Q50171944 | Recent and upcoming randomized trials for left atrial appendage occlusion : Need for a definite assessment of the situation |
| Q88674203 | Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring |
| Q92584801 | Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation |
| Q64119791 | Red Cell Distribution Width as a Novel Marker for Different Types of Atrial Fibrillation in Low and High Altitude |
| Q100317984 | Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator |
| Q50201381 | Relationship between left ventricular diastolic dysfunction and very late recurrences after multiple procedures for atrial fibrillation ablation |
| Q90040860 | Remote Monitoring of Atrial High Rate Episodes in Pacemaker Patients. The Rapid Study Design |
| Q41995752 | Renal failure caused by a partly calcified aortic aneurysm in a patient with dabigatran therapy: A case report |
| Q57046331 | Repeat ablation for paroxysmal atrial fibrillation - Does adenosine play a role in predicting pulmonary vein reconnection patterns? |
| Q38375044 | Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time |
| Q30313291 | Repetitive atrial activation during ongoing atrial fibrillation-comparison using different mapping algorithms: preliminary findings. |
| Q37390016 | Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy. |
| Q48179821 | Retrospective Evaluation of the Effect of Heart Rate on Survival in Dogs with Atrial Fibrillation |
| Q92277166 | Rhythm Control in AF: Have We Reached the Last Frontier? |
| Q99615004 | Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome |
| Q91952642 | Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation |
| Q64112856 | Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score |
| Q93141661 | Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation |
| Q89542329 | Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study |
| Q58700299 | Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study |
| Q64067478 | Rivaroxaban concentrations in acute stroke patients with different dosage forms |
| Q39000216 | Role of hospitalists in the diagnosis of atrial fibrillation for the management of cryptogenic stroke patients |
| Q90029290 | Role of the anticoagulant monitoring service in 2018: beyond warfarin |
| Q94677081 | Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study |
| Q64231843 | Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study |
| Q47294689 | Safety and efficacy analysis of one-stop intervention for treating nonvalvular atrial fibrillation |
| Q55113397 | Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials. |
| Q48063394 | Safety and efficacy of pulmonary vein isolation using a surround flow catheter with contact force measurement capabilities: A multicenter registry. |
| Q91339213 | Safety and efficacy of the ThermoCool SmartTouch SurroundFlow catheter for atrial fibrillation ablation: A meta-analysis |
| Q47190106 | Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry |
| Q89674787 | Safety of Catheter Ablation of Atrial Fibrillation Under Uninterrupted Rivaroxaban Use |
| Q92334049 | Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial |
| Q91771891 | Screening for atrial fibrillation: a call for evidence |
| Q47653704 | Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice |
| Q47707036 | Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis |
| Q57170279 | Second-generation cryoballoon ablation for recurrent atrial fibrillation after an index cryoballoon procedure: a staged strategy with variable balloon size |
| Q38597914 | Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines |
| Q90664951 | Selective inhibition of electrical conduction within the pulmonary veins by α1-adrenergic receptors activation in the Rat |
| Q93005645 | Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study |
| Q38752144 | Severity of Hypertension Correlates with Risk of Thromboembolic Stroke |
| Q55499184 | Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population-Based Tromsø Study. |
| Q38682802 | Sex differences in health status and rehabilitation outcomes in patients with atrial fibrillation treated with ablation: Results from the CopenHeartRFA trial |
| Q47758291 | Shared Decision-Making as the Future of Emergency Cardiology |
| Q57453635 | Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient |
| Q50591989 | Significant reduction in procedure duration in remote magnetic-guided catheter ablation of atrial fibrillation using the third-generation magnetic navigation system. |
| Q50659810 | Significant reduction of radiation exposure in cryoballoon-based pulmonary vein isolation. |
| Q47260319 | Single trans-septal access technique for left atrial intracardiac echocardiography to guide left atrial appendage closure. |
| Q55176626 | Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants. |
| Q92447909 | Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease |
| Q58129758 | Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHADS-VASc Scores: Findings From the ORBIT-AF I and II Registries |
| Q58719921 | Stroke prevention in Europe: how are 11 European countries progressing toward the European Society of Cardiology (ESC) recommendations? |
| Q92378495 | Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry |
| Q92703557 | Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice |
| Q88873899 | Subclinical atrial fibrillation frequency and associated parameters in patients with cardiac resynchronization therapy |
| Q55255779 | Subclinical atrial fibrillation in need of more assertive evidence. |
| Q92590922 | Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis |
| Q57183446 | Successful radiofrequency catheter ablation of atrial fibrillation is associated with improvement in left ventricular energy loss and mechanics abnormalities |
| Q64950050 | Successful transseptal puncture and cryoballoon ablation of symptomatic paroxysmal atrial fibrillation via jugular access in a patient with bilateral thrombotic femoral vein occlusion. |
| Q41061222 | Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease |
| Q47226357 | Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. |
| Q59811846 | Surgical left atrial appendage occlusion during cardiac surgery: A systematic review and meta-analysis |
| Q41698156 | Surgical management of atrial fibrillation at the time of septal myectomy |
| Q53838113 | Surrogate endpoints in heart failure: (once again) use with caution. |
| Q55416527 | Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe. |
| Q46731211 | Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey |
| Q47668709 | Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study |
| Q64279254 | TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease |
| Q90656613 | TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation |
| Q64102108 | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach |
| Q50193584 | Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation |
| Q47827668 | Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? |
| Q61817426 | Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study |
| Q97544623 | Thawing Rate Predicts Acute Pulmonary Vein Isolation after Second-Generation Cryoballoon Ablation |
| Q49981094 | The 125th anniversary of the His bundle discovery |
| Q52625470 | The Cox-maze IV procedure in its second decade: still the gold standard? |
| Q92712464 | The Difference in the Changes of Indoxyl Sulfate after Catheter Ablation among Atrial Fibrillation Patients with and without Kidney Dysfunction |
| Q59807214 | The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study |
| Q38654986 | The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study |
| Q38373211 | The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial |
| Q99555753 | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
| Q61817022 | The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting |
| Q50098979 | The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy |
| Q46139654 | The Significance Of Troponin Elevation In Atrial Fibrillation |
| Q88692132 | The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model |
| Q88610793 | The best of two worlds? Pulmonary vein isolation using a novel radiofrequency ablation catheter incorporating contact force sensing technology and 56-hole porous tip irrigation |
| Q91772558 | The clinical outcomes of patients who developed typical atrial flutter on class 1C anti arrhythmic medications treated with hybrid approach |
| Q90353557 | The imminent epidemic of atrial fibrillation and its concomitant diseases - Myocardial infarction and heart failure - A cause for concern |
| Q97538029 | The impact of beta-blocker use on postoperative atrial fibrillation after aortic valve replacement |
| Q55100564 | The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old. |
| Q90107434 | The importance of bipolar bidirectional radiofrequency in surgical AF ablation |
| Q38636940 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. |
| Q47744006 | The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey |
| Q55346953 | The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation. |
| Q50084283 | The path to becoming more efficacious: modern perspectives in the surgical treatment of atrial fibrillation |
| Q94677086 | The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non-valvular atrial fibrillation patients |
| Q38735704 | The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients |
| Q58580630 | The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction |
| Q55453854 | The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. |
| Q57788635 | The safety and efficacy of second-generation cryoballoon ablation plus catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis |
| Q58377760 | The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation |
| Q90145568 | Thermodynamic properties of atrial fibrillation cryoablation: a model-based approach to improve knowledge on energy delivery |
| Q50001069 | Thoracoscopic left atrial appendage clipping as novel treatment option for peri-device leakage |
| Q64234324 | Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial |
| Q89037273 | Time in Therapeutic Range of Oral Vitamin K Antagonists in Hospitalized Elderly Patients |
| Q64063004 | Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry |
| Q92076654 | Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry |
| Q48526644 | Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. |
| Q55402945 | Treatment of Atrial Fibrillation in Patients with Co-existing Heart Failure and Reduced Ejection Fraction: Time to Revisit the Management Guidelines? |
| Q89153310 | Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017 |
| Q98947013 | Trimethylamine N-oxide in atrial fibrillation progression |
| Q60936109 | Two causes of palpitations, detected by photoplethysmography on a mobile phone |
| Q47429445 | Two-staged hybrid ablation of non-paroxysmal atrial fibrillation: clinical outcomes and functional improvements after 1 year |
| Q47789803 | Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism |
| Q90610508 | Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience |
| Q47576719 | Use of oral anticoagulants in German nursing home residents: drug use patterns and predictors for treatment choice |
| Q38941684 | Use of rivaroxaban in patients with stroke |
| Q48197551 | Usefulness of left ventricular speckle tracking echocardiography and novel measures of left atrial structure and function in diagnosing paroxysmal atrial fibrillation in ischemic stroke and transient ischemic attack patients. |
| Q38650779 | Vagal denervation in atrial fibrillation ablation: A comprehensive review |
| Q91633064 | Validation of Single Centre Pre-Mobile Atrial Fibrillation Apps for Continuous Monitoring of Atrial Fibrillation in a Real-World Setting: Pilot Cohort Study |
| Q92003766 | Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy |
| Q51411747 | Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy. |
| Q54940282 | Vitamin K antagonist use and renal function in pre-dialysis patients. |
| Q88673560 | [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management] |
| Q88092161 | [Choosing wisely recommendations in angiology] |
| Q104755191 | [Diagnosis, Prevention and Treatment of Cardiovascular Disease in People with Diabetes and Prediabetes] |
| Q88983094 | Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018 |
Search more.